ADHD-Adderall Label Warnings Added Re: Cardiovascular, Psychosis

The American Society of Health System Pharmacists reports that the FDA "directed all makers of ADHD stimulants in May to strengthen the wording in the "Warnings" section of the labeling "with regard to serious cardiovascular events and psychiatric events."
Continue reading →

Psychiatrist criminally indicted: Promoting off-label use of drug for depression!

The New York Times reports that a Maryland psychiatrist, Dr. Peter Gleason, was handcuffed and arrested in March and charged with criminal promotion of a drug "for purposes other than those approved by the federal government."
Continue reading →

Staff Survey Confirms FDA Officials Tamper with Science_ Grassley Seeks Investigation of FDA

Bloomberg News reports (below) that Senator Charles Grassley has asked the Inspector General to investigate collusion between FDA officials and Merck. Citing handwritten notes prepared by a Merck executive document a meeting with FDA division director, Brian Harvey, suggesting a joint effort . . . Continue reading →

A Matter of Disclosure: Shame on JAMA editor / Shame on Harvard Scientists / FDA Adds SSRIWarnings

The Associated Press reports (1, 2 below) that the FDA has just issued new warnings about two additional life-threatening risks induced by SSRI antidepressants: Serotonin Syndrome and Persistent Pulmonary Hypertension in newborn babies.
Continue reading →

Is this the perfect storm of corruption? ACNP journal

The Wall Street Journal and Bloomberg News report about a case involving Neuropsychopharmacology, the official journal of the American College of Neuropsychopharmacology (ACNP) that will likely go down in history as psychiatry’s Watergate.
Continue reading →